Association between increased nuchal translucency and second trimester cardiac echogenic foci

Obstetrics and Gynecology

Volumn 101, Issue 5, 2003, Pages 899-904

  Prefumo, Federico ^a   Presti, Francesca ^a   Thilaganathan, Baskaran ^a   Carvalho, Julene S ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RISK; SECOND TRIMESTER PREGNANCY; VAGINAL DELIVERY;

EID: 0037728588     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/s0029-7844(02)03128-9     Document Type: Article

References (39)

1. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998;351:343-6.
2. De Biasio P, Siccardi M, Volpe G, Famularo L, Santi F, Canini S. First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy: the combined test. Prenat Diagn 1999;19:360-3.
3. Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 1996;7:245-50.
4. Carvalho JS. Nuchal translucency, ductus venosus and congenital heart disease: An important association, a cautious analysis. Ultrasound Obstet Gynecol 1999;14:302-6.
5. Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001;17:102-5.
6. Mavrides E, Cobian-Sanchez F, Tekay A, Moscoso G, Campbell S, Thilaganathan B, et al. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001;17:106-10.
7. How HY, Villafane J, Parihus RR, Spinnato JA. Small hyperechoic foci of the fetal cardiac ventricle: A benign sonographic finding? Ultrasound Obstet Gynecol 1994;4:205-7.
8. Levy DW, Mintz MC. The left ventricular echogenic focus: A normal finding. AJR Am J Roentgenol 1988;150:85-6.
9. Dildy GA, Judd VE, Clark SL. Prospective evaluation of antenatal incidence and postnatal significance of the fetal echogenic cardiac focus: A case-control study. Am J Obstet Gynecol 1996;175:1008-12.
10. Merati R, Lovotti M, Norchi S, Teatini A, Tenore AC, Belloni C. Prevalence of fetal left ventricular hyperechogenic foci in a low risk population. Br J Obstet Gynaecol 1996;103:1102-4.
11. Achiron R, Lipitz S, Gabbay U, Yagel S. Prenatal ultrasonographic diagnosis of fetal heart echogenic foci: No correlation with Down syndrome. Obstet Gynecol 1997; 89:945-8.
12. Thilaganathan B, Olawaiye A, Sairam S, Harrington K. Isolated fetal echogenic foci or golf balls: Is karyotyping for Down's syndrome indicated? Br J Obstet Gynaecol 1999; 106:1294-7.
13. Prefumo F, Presti F, Mavrides E, Sanusi AF, Bland JM, Campbell S, et al. Isolated echogenic foci in the fetal heart: Do they increase the risk of trisomy 21 in a population previously screened by nuchal translucency? Ultrasound Obstet Gynecol 2001;18:126-30.
14. Simpson JM, Cook A, Sharland G. The significance of echogenic foci in the fetal heart: A prospective study of 228 cases. Ultrasound Obstet Gynecol 1996;8:225-8.
15. Vibhakar NI, Budorick NE, Scioscia AL, Harby LD, Mullen ML, Sklansky MS. Prevalence of aneuploidy with a cardiac intraventricular echogenic focus in an at-risk patient population. J Ultrasound Med 1999;18:265-8.
16. Jaffe R, Cherot E, Allen T, Glantz JC. Significance of echogenic foci in the left ventricle of the fetal heart in a low-risk population. Fetal Diagn Ther 1999;14:345-7.
17. Huggon IC, Cook AC, Simpson JM, Smeeton NC, Sharland GK. Isolated echogenic foci in the fetal heart as a marker of chromosomal abnormality. Ultrasound Obstet Gynecol 2001;17:11-6.
18. Wolman I, Jaffa A, Geva E, Diamant S, Strauss S, Lessing JB, et al. Intracardiac echogenic focus: No apparent association with structural cardiac abnormality. Fetal Diagn Ther 2000;15:216-8.
19. Wax JR, Mather J, Steinfeld JD, Ingardia CJ. Fetal intracardiac echogenic foci: Current understanding and clinical significance. Obstet Gynecol Surv 2000;55:303-11.
20. Shinebourne EA, Macartney FJ, Anderson RH. Sequential chamber localization—logical approach to diagnosis in congenital heart disease. Br Heart J 1976;38:327-40.
21. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002;88:387-91.
22. Royston P, Wright EM. How to construct ‘normal ranges’ for fetal variables. Ultrasound Obstet Gynecol 1998;11:30-8.
23. Pearson EG, Hartley HO. Biometrika tables for statisticians, volume 1, 3rd ed. Cambridge, United Kingdom: Cambridge University Press, 1970.
24. Bland M. An introduction to medical statistics. Oxford, United Kingdom: Oxford University Press, 2000:240-3.
25. Bland M. An introduction to medical statistics. Oxford, United Kingdom: Oxford University Press, 2000:321-3.
26. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 10-14 weeks: The role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998;12:380-4.
27. Borrell A, Antolin E, Costa D, Farre MT, Martinez JM, Fortuny A. Abnormal ductus venosus flow in trisomy 21 fetuses during early pregnancy. Am J Obstet Gynecol 1998;179:1612-7.
28. Mavrides E, Sairam S, Hollis B, Thilaganathan B. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus. Br J Obstet Gynaecol 2002;109:1015-9.
29. Bilardo CM, Müller MA, Zikulnig L, Schipper M, Hecher K. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: Relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001;17:288-94.
30. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased fetal nuchal translucency: Possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10:265-8.
31. Brown DL, Roberts DJ, Miller WA. Left ventricular echogenic focus in the fetal heart: Pathologic correlation. J Ultrasound Med 1994;13:613-6.
32. Tennstedt C, Chaoui R, Vogel M, Goldner B, Dietel M. Pathologic correlation of sonographic echogenic foci in the fetal heart. Prenat Diagn 2000;20:287-92.
33. Degani S, Leibovitz Z, Shapiro I, Gonen R, Ohel G. Cardiac function in fetuses with intracardiac echogenic foci. Ultrasound Obstet Gynecol 2001;18:131-4.
34. Friedman WF. The intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis 1972;15:87-111.
35. Leiva MC, Tolosa JE, Binotto CN, Weiner S, Huppert L, Denis AL, et al. Fetal cardiac development and hemodynamics in the first trimester. Ultrasound Obstet Gynecol 1999;14:169-74.
36. Bilardo CM. Increased nuchal translucency and normal karyotype: Coping with uncertainty. Ultrasound Obstet Gynecol 2001;17:99-101.
37. Bilardo CM, Pajkrt E, de Graaf I, Mol BW, Bleker OP. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998;11:401-6.
38. Hiippala A, Eronen M, Taipale P, Salonen R, Hiilesmaa V. Fetal nuchal translucency and normal chromosomes: A long-term follow-up study. Ultrasound Obstet Gynecol 2001;18:18-22.
39. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001;18:9-17.